Author:
Fox Caroline S.,Golden Sherita Hill,Anderson Cheryl,Bray George A.,Burke Lora E.,de Boer Ian H.,Deedwania Prakash,Eckel Robert H.,Ershow Abby G.,Fradkin Judith,Inzucchi Silvio E.,Kosiborod Mikhail,Nelson Robert G.,Patel Mahesh J.,Pignone Michael,Quinn Laurie,Schauer Philip R.,Selvin Elizabeth,Vafiadis Dorothea K.
Abstract
Cardiovascular disease risk factor control as primary prevention in patients with type 2 diabetes mellitus has changed substantially in the past few years. The purpose of this scientific statement is to review the current literature and key clinical trials pertaining to blood pressure and blood glucose control, cholesterol management, aspirin therapy, and lifestyle modification. We present a synthesis of the recent literature, new guidelines, and clinical targets, including screening for kidney and subclinical cardiovascular disease for the contemporary management of patients with type 2 diabetes mellitus.
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
505 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献